Molecular Axiom
Fangcun · Founded 2022
About Molecular Axiom
Molecular Axiom is a biotechnology company that engages in nucleic acid drug discovery, clinical development, and commercialization.
Company Facts
- Founded: 2022
- Legal name: Shanghai Weizhemoli Biotechnology Co., Ltd.
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Funding stage: Early Stage Venture
- Last round: Series A (Dec 2022)
- Website: molecularaxiom.com
Social Profiles
Canonical: https://fsome.com/organization/molecular-axiom-8422321 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.